ClinicalTrials.gov
public full text
Public Domain
Validation of Ferromagnetic Tracer in Melanoma Sentinel Node
This study has been designed to validate a non-radioactive method to identify the sentinel lymph node using a superparamagnetic iron-oxide (SPIO) tracer respect to the traditional isotopic method. Both methods are used in every included patient and each patient is its own control.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sienna+MR Long-term Uptake#1140571
- Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma#979870
- Construction and validation of a pretreatment DCE-MRI-based radiomics prediction model for axillary pathologic response after neoadjuvant therapy in node-positive breast cancer.#280912
- A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma#907607
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC#837584
Record · ID 982546
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive